RxDoctor Payments DataLook up a doctor →

Selwyn Spangenthal, MD

Pulmonary Disease · Charlotte, NCNPI 1710975297

Payments from drug & device makers

$6,981,658in general payments, 2019–2025

Across 941 payments — averaging $7419.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$3.1M
  • Genentech, Inc.$681K
  • AstraZeneca$638K
  • GSK$494K
  • Verona Pharma, Inc.$487K
  • Novartis$366K
  • plus $1.3M from 36 others
$3,668in research payments, 2019–2025

Across 31 payments — averaging $118.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$2K
  • Sanofi US Services Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$59

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,981,658 in reported general payments places this provider in the 95th percentile of 393 pulmonary disease providers in North Carolina.

See all pulmonary disease providers in North Carolina

Medicare billing

Part B allowed, 2024
$62,462
Medicare patients
103
Services billed
945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →